CompletedPhase 1NCT04894110

Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

Studying Corneal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emmecell
Principal Investigator
Noelia Kunzevitzky
Emmecell
Intervention
EO2002(biological)
Enrollment
42 enrolled
Eligibility
21 years · All sexes
Timeline
20212024

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04894110 on ClinicalTrials.gov

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Corneal dystrophy

← Back to all trials